API CAS 41340-25-4 Etodolac Raw Material Etodolac Powder Purity Etodolac

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: D-sung-Etodolac
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Etodolac
• Name: Etodolac Powder
• Appearance: White Powder
• Color: White Color
• Grade: Pharmaceutical Grade
• Assay: 99%
• Specific: COA
• Test Method: HPLC, UV
• CAS: 41340-25-4
• Mf: C17h21no3
• MW: 287.35
• Melting Point: 145-148
• Boiling Point: 507.9
• Stability: Stable
• Shelf Life: 2 Years
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• Production Capacity: 9000kg/Month

Product Description

API CAS 41340-25-4 Etodolac Raw Material Etodolac Powder Purity Etodolac

Product Description

Product Details

 

Product Name:	Etodolac
CAS:	41340-25-4
MF:	C17H21NO3
MW:	287.35
EINECS:	629-689-1

Etodolac (etodolic acid) is a non-steroidal antiinflammatory/analgesic agent useful in the treatment of
various inflammatory conditions, including rheumatoid and osteoarthritis.
For acute and long-term management of signs and symptoms of osteoarthritis and rheumatoid arthritis,
as well as for the management of pain.

Application&Function

Etodolac (trade name: Lodine), also known as ethoxycolic acid, indoleacetic acid, and rhododine, is a new generation of non-steroidal anti-inflammatory drug highly selective to COX-2. This product is a weak acidic drug, existing in a molecular form under the condition of lower pH value which is conducive to drug absorption. This product is widely used in the clinical treatment of postoperative pain. It has analgesic and anti-inflammatory effects, being able to relieve the symptoms of rheumatoid arthritis and osteoarthritis, delaying the pathological changes caused by arthritis. In inflammatory site, it can selectivity inhibit the prostaglandin synthesis to exert its anti-inflammatory effect. It is especially applicable to the elderly patients. This product appears as white crystalline powder with the melting point of 145~148 ºC.
Etodolac was first developed by a subsidiary of AHP in the United States. It had been successfully listed in the UK in 1985, followed by being listed in France, the United States, Germany, Japan and other countries.

Specification